This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

More than 75% of adults in a virtual asthma self-management education program had improved asthma control afterward, according to data presented at the American Academy of Allergy, Asthma & Immunology ...

People living with asthma understand that their environment affects their health, but they’re often left without the tools, guidance, or support to fully act on that knowledge. In this virtual event, ...

In a new study, researchers have used a urine test to identify and verify a patient's type of asthma. The study lays the foundation for a more personalized diagnosis and may result in improved ...

Bedfont ® Scientific Limited, an innovative med-tech company specializing in medical breath analysis devices, welcomes the new study at University Hospital Southampton exploring whether enhanced ...

Tezspire (tezepelumab-ekko) is a monthly injection used to treat severe asthma. It was approved by the FDA in 2021 for use in addition to other asthma controlling medicines in people 12 and older.

Asthma care continues to develop, particularly in how treatment and long-term management are approached. This article outlines current treatment and management recommendations for patients aged 12 and ...

Scientists working in the School of Biochemistry and Immunology at the Trinity Biomedical Sciences Institute (TBSI) report they have uncovered a new strategy in mice for treating severe asthma. The ...

Despite the name, cardiac asthma isn’t a type of asthma. It refers to breathing difficulty caused by fluid buildup in the lungs as a result of heart failure. Cardiac asthma can be potentially life ...

Exposure to more germs may backfire for adult asthma sufferers In A Nutshell A new mouse study from Cornell University found that adult mice exposed to a wide variety of microbes developed more severe ...